针对三阴性乳腺癌:临床视角
Lazar S Popovic1,2, Gorana Matovina-Brko1, Maja Popovic1,2
1Department of Medical Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia.
Oncology research
|June 12, 2023
概括
三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性疾病. 本综述涵盖了TNBC患者的当前和新兴疗法,包括免疫疗法和向治疗.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
- 乳腺癌的TNBC占乳腺癌病例的10-15%,代表着一个重要的未满足的医疗需求.
- 从历史上看,化疗是TNBC的唯一全身治疗方法.
研究的目的:
- 为TNBC提供当前和研究中的治疗选择的最新概述.
- 讨论TNBC的异质性及其不断变化的分类.
- 突出治疗策略的进步超越传统化疗.
主要方法:
- 审查关于TNBC分类和治疗方式的现有文献.
- 对用于TNBC亚型的mRNA表达数据的分析 (Lehman等人,2011).
- 纳入基于瘤透性淋巴细胞和干细胞透的TNBC亚型修订的最新发现.
主要成果:
- TNBC分类已经从六个亚型演变为四个:基底1,基底2,光雄激素受体 (LAR) 和介质细胞.
- 新的治疗策略包括免疫疗法,抗体药物合物,新型化疗剂和向疗法正在调查中.
- 在开发TNBC的替代治疗方案方面取得了重大进展.
结论:
- 甲状腺癌是一种异质性疾病,需要不同的治疗方法.
- 新兴的治疗方法为TNBC患者提供了新的希望.
- 持续的研究对于优化TNBC管理至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K